FSMAX | TMCTX | FSMAX / TMCTX | |
Total Expense Ratio | 0.04 | 1.21 | 3% |
Annual Report Gross Expense Ratio | 0.04 | 1.24 | 3% |
Fund Existence | 14 years | 19 years | - |
Gain YTD | 6.140 | 1.880 | 327% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 39.6B | 5.47B | 724% |
Annual Yield % from dividends | 0.46 | 0.00 | - |
Returns for 1 year | 16.65 | 1.82 | 914% |
Returns for 3 years | 34.54 | 21.61 | 160% |
Returns for 5 years | 52.87 | 41.49 | 127% |
Returns for 10 years | 84.94 | 116.63 | 73% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSTKX | 20.13 | 0.09 | +0.45% |
Goldman Sachs International Eq Inc Inv | |||
FZANX | 50.30 | -0.10 | -0.20% |
Fidelity Advisor New Insights Z | |||
PTEZX | 23.87 | -0.06 | -0.25% |
PGIM Quant Solutions Large-Cap Cor Eq Z | |||
ICTEX | 16.74 | -0.08 | -0.48% |
ICON Health and Information Tech Instl | |||
ODMCX | 10.88 | -0.08 | -0.73% |
JPMorgan SMID Cap Equity C |